Health
NIH Worried About Side Effect in Coronavirus Vaccine Trial – Medscape
The AstraZeneca trial is on hold in the U.S. as scientists try to unravel whether a rare neurologic condition is linked to the vaccine.
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case.
“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral rese…
Continue Reading